Shoreline Biosciences
PrivateLast Round
Series B
Nov 2, 2021
Est. Valuation
$68.3M
Total Funding Raised
$186M
Momentum Score
25 /100
Company Overview
Shoreline Biosciences is a biotechnology company specializing in the development of innovative immunotherapies utilizing engineered Induced Pluripotent Stem Cells (iPSC)-derived NK cells and macrophages for oncology and disease modification.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shoreline Biosciences Comps
Public and private peers based on sector, stage, and business model.
Shoreline Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 2, 2021 | ||||
| Series A | Apr 7, 2021 | ||||
| Seed | Jul 1, 2020 |
Shoreline Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stork Capital | Series B, Series A, Seed |
| Janus Henderson Group | Series B, Series A |
| Wedbush Healthcare Partners | Series B, Series A |
| Boxer Capital | Series B, Series A |
| Ally Bridge Group | Series B |
| Heartland Healthcare Capital | Series B |
| Eventide Funds | Series B |
Shoreline Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shoreline Biosciences's valuation, stock price, and market status.
